Wren Capital

Type

Other

Status

Active

Location

London, United Kingdom

Total investments

32

Average round size

4M

Portfolio companies

24

Rounds per year

2.46

Follow on index

0.25

Exits

3

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsGeneticsAerospaceMedical DeviceMedicalTherapeuticsHardwareBiopharma

Summary

Wren Capital is the famous VC, which was founded in 2011. The main department of described VC is located in the London. The venture was found in Europe in United Kingdom.

The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2019. The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2013. This Wren Capital works on 16 percentage points less the average amount of lead investments comparing to the other organizations.

Among the most successful fund investment fields, there are Pharmaceutical, Medical Device. Among the most popular portfolio startups of the fund, we may highlight LumeJet, Momentum Bioscience, Monica Healthcare. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Wren Capital, startups are often financed by UK Innovation & Science Seed Fund, Midven, Catapult Ventures. The meaningful sponsors for the fund in investment in the same round are UK Innovation & Science Seed Fund, Parkwalk Advisors, Newable Private Investing. In the next rounds fund is usually obtained by Parkwalk Advisors, Midven, IQ Capital.

This organization was formed by Rajat Malhotra. Besides them, we counted 1 critical employee of this fund in our database.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
32
Lead investments
0
Exits
3
Rounds per year
2.46
Follow on index
0.25
Investments by industry
  • Biotechnology (20)
  • Health Care (9)
  • Hardware (5)
  • Medical Device (5)
  • Biopharma (4)
  • Show 33 more
Investments by region
  • United Kingdom (32)
Peak activity year
2013

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
16M
Group Appearance index
0.97
Avg. company exit year
11
Avg. multiplicator
7.85

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Adapttech 06 Apr 2022 Biotechnology, Medical Device Early Stage Venture 3M England, Birmingham, United Kingdom
Rentals United 10 Nov 2014 Software, B2B, SaaS, Travel, Hospitality Seed 678K Spain, Barcelona, Catalonia
Spectral Edge 22 Mar 2016 Software, Artificial Intelligence, Machine Learning, Software Engineering Seed 2M England, Cambridge, United Kingdom

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.